Rekord LOINC: 77349-9
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
77349-9
FHIR
|
| Long Common Name: | Everolimus [Mass/volume] in Blood by LC/MS/MS --trough |
| Short Name: | Everolimus Trough Bld LC/MS/MS-mCnc |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
EN
Oryginalna wersja angielska
Everolimus^trough
:
MCnc
:
Pt
:
Bld
:
Qn
:
LC/MS/MS
Klasyfikacja
| Class: |
ENDRUG/TOX
|
| Consumer Name: | - |
| Order/Observation: | Both |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | ng/mL |
| UCUM Units: | ng/mL |
| Version Last Changed: | 2.73 |
Definicja i opis
EN
Trough blood levels of everolimus is performed for therapeutic monitoring and dose individualization. Koster et. al. (2009) reported a systematic deviation in blood levels of everolimus (30% lower) measured by LC-MS/MS compared with immunoassays.[PMID: 19065123] Everolimus may be used to treat patients post transplant (e.g, kidney transplant) or with tuberous sclerosis complex (TSC) who have subependymal giant cell astrocytoma (SEGA). Maintaining everolimus troughs between 3-8 ng/mL is recommended for patients post transplant. Maintaining trough levels of 5 to 15 ng/mL is recommended in pediatric and adult patients with SEGA.
Powiązane nazwy
Afinitor; Blood; Certican; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; RAD-001; Random; WB; Whole blood; Zortress